Better Glycaemic Outcome, Low Levels of Acute Severe Complications, and High Patient Satisfaction in Routine Practice in Type 1 Diabetes Treated with an Insulin Pump


Treatment of patients with Type 1 diabetes with continuous subcutaneous insulin infusion (CSII) was re-introduced in Denmark in this millennium and initiated in the diabetes clinic, Fredericia Hospital, in 2005. The aim of the present study was to present yearly data of quality from 2005 to 2013 from a clinical database of patients treated with CSII in routine practice. Methods: A database was established in 2009-2010. Data from 2005 to 2009 are retrospective, data from 2009 to 2013 prospective. From 2009, patient satisfaction was measured by validated questionnaires. Results: By 31 December 2013, the database contained data from 143 active patients. HbA1C (median and range) decreased from 64 (40 - 126) mmol/mol (8.0 (5.8 - 13.7)%) (n = 104) to 60 (36 - 98) mmol/mol (7.6 (5.4 - 11.1)%) (n = 134) (p < 0.001) before and latest year on CSII. The improved glycaemic control was maintained each year until ≥5 years after initiation of CSII (p < 0.01). There was no change in weight. The number of attacks of severe hypoglycaemia was reduced from 60 attacks in 21 patients (n = 104) the year before CSII to only 5 attacks in 5 patients in 2013 (n = 134) (p < 0.01), corresponding to an incidence of 3.7 episodes per 100 patient years. Each year after initiation of CSII until ≥5 years, the number of episodes of severe hypoglycaemia was reduced (p < 0.01). Since 2005, nine episodes of ketoacidosis have been registered in eight patients corresponding to an incidence of 1.4 episodes per 100 patient years. Patient satisfaction was high one year after initiation of CSII (p < 0.01). Conclusion: Change of treatment to CSII is accompanied by an improvement in glycaemic control, very pronounced reduction in severe hypoglycaemia, low levels of diabetic ketoacidosis, and pronounced patient satisfaction.

Share and Cite:

Gjessing, H. , Jørgensen, U. , Møller, C. , Pedersen, J. , Grodum, E. and Schousboe, K. (2014) Better Glycaemic Outcome, Low Levels of Acute Severe Complications, and High Patient Satisfaction in Routine Practice in Type 1 Diabetes Treated with an Insulin Pump. Journal of Diabetes Mellitus, 4, 304-310. doi: 10.4236/jdm.2014.44042.

Conflicts of Interest

The authors declare no conflicts of interest.


[1] Egger, M., Smith, G.D., Stettler, C. and Diem, P. (1997) Risk of Adverse Effects of Intensified Treatment in Insulin-Dependent Diabetes Mellitus: A Meta-Analysis. Diabetic Medicine, 14, 919-928.<919::AID-DIA456>3.0.CO;2-A
[2] Norgaard, K. (2003) A Nationwide Study of Continuous Subcutaneous Insulin Infusion (CSII) in Denmark. Diabetic Medicine, 20, 307-311.
[3] Norgaard, K. and Olsen, B. (2011) Changing Denmark from a Non-User Country to a Place Using Insulin Pumps—A Story on the Initiatives Taken. Infusystems International, 10, 25-29.
[4] Marmolin, E.A., Brodsgaard, J., Gjessing, H.J., Schousboe, K., Grodum, E., Jorgensen, U.L., et al. (2012) Better Treatment of Outpatients with Type 1 Diabetes after Introduction of Continuous Subcutaneous Insulin Infusion. Danish Midical Journal, 59, A4445.
[5] Gjessing, H.J., Jorgensen, U.L., Moller, C.C., Pedersen, J., Grodum, E. and Schousboe, K. (2013) Clinical Experiences with Continuous Insulin Infusion—Improved Glycaemic Control, Less Hypoglycaemia and Better and Pronounced Patient Satisfaction. Infusystems USA, 10, 1-5.
[6] Bradley, C. (1994) The Diabetes Treatment Satisfaction Questionnaire: DTSQ. In: Bradley, C., Ed., Handbook of Psychology and Diabetes: A Guide to Psychological Measurement in Diabetes Research and Practice, Harwood Academic Publishers, Chur, 111-132.
[7] Bradley, C. (1999) The Diabetes Treatment Satisfaction Questionnaire (DTSQ): Change Version for Use Alongside Status Version Provides Appropriate Solution Where Ceiling Effects Occur. Diabetes Care, 22, 530-532.
[8] _final_offentligg%C3%B8relse.pdf
[9] Pickup, J. (2011) Insulin Pumps. International Journal of Clinical Practice, 65, 16-19.
[10] White, H.D., Goenka, N., Furlong, N.J., Saunders, S., Morrison, G., Langridge, P., et al. (2014) The UK Service Level Audit of Insulin Pump Therapy in Adults. Diabetic Medicine, 31, 412-418.
[11] Swedish National Diabetes Register (2013) Annual Report 2013.
[12] Yeh, H.-C., Brown, T.T., Maruthur, N., Ranasinghe, P., Berger, Z., Suh, Y.D., et al. (2012) Comparative Effictiveness and Safety of Methods of Insulin Delivery and Glucose Monitoring for Diabetes Mellitus: A Systematic Review and Meta-Analysis. Annals of Internal Medicine, 157, 336-347.
[13] Fatourechi, M.M., Kudva, Y.C., Murad, M.H., Elamin, M.B., Tabini, C.C. and Montori, V.M. (2009) Hypoglycemia with Intensive Insulin Therapy: A Systemic Review and Meta-Analysis of Randomised Trials of Continuous Subcutaneous Insulin Infusion versus Multiple Daily Injections. The Journal of Clinical Endocrinology and Metabolism, 94, 729-740.
[14] Pickup, J.C. and Sutton, A.J. (2008) Severe Hypoglycaemia and Glycaemic Control in Type 1 Diabetes: Meta-Analysis of Multiple Daily Insulin Injections Compared with Continuous Subcutaneous Insulin Infusion. Diabetic Medicine, 25, 765-774.
[15] The Juvenile Diabetes Research Foundation Continuous Glucose Monitoring Study Group (2008) Continuous Glucose Monitoring and Intensive Treatment of Type 1 Diabetes. The New England Journal of Medicine, 359, 1464-1476.
[16] Pedersen-Bjergaard, U., Pramming, S. and Thorsteinsson, B. (2003) Recall of Severe Hypoglycaemia and Self-Estimated State of Awareness in Type 1 Diabetes. Diabetes/Metabolism Research and Reviews, 19, 232-240.
[17] Pedersen-Bjergaard, U., Pramming, S., Heller, S.R., Wallace, T.M., Rasmussen, A.K., J?rgensen, H.V., et al. (2004) Severe Hypoglycaemia in 1076 Adult Patients with Type 1 Diabetes: Influence of Risk Markers and Selection. Diabetes/Metabolism Research and Reviews, 20, 479-486.
[18] Shalitin, S., Gil, M., Nimri, R., de Vries, L., Gavan, M.Y. and Philip, M. (2010) Predictors of Glycaemic Control in Patients with Type 1 Diabetes Commencing Continuous Subcutaneous Insulin Infusion Therapy. Diabetic Medicine, 27, 339-347.
[19] Bergenstal, R.M., Klonoff, D.C., Garg, S.K., Bode, B.W., Meredith, M., Slover, R.H., et al. (2013) Threshold-Based Insulin Pump Interruption for Reduction of Hypoglycemia (Aspire In-Home Study). The New England Journal of Medicine, 369, 224-232.
[20] Ly, T.T., Nicholas, J.A., Retterath, A., Lim, E.M., Davis, E.A. and Jones, T.W. (2013) Effect of Sensor-Augmented Insulin Pump Therapy and Automated Insulin Suspension vs Standard Insulin Pump Therapy on Hypoglycaemia in Patients with Type 1 Diabetes. A Randomized Clinical Trial. Journal of the American Medical Association, 310, 1240-1247.
[22] Henriksen, O.M., Roder, M.E., Prahl, J.B. and Svendsen, O.L. (2007) Diabetic Ketoacidosis in Denmark. Incidence and Mortality Estimated from Public Health Registries. Diabetes Research and Clinical Practice, 76, 51-56.
[23] Barnard, K.D., Lloyd, C.E. and Skinner, T.C. (2007) Systemic Literature Review: Quality of Life Associated with Insulin Pump Use in Type 1 Diabetes. Diabetic Medicine, 24, 607-617.
[24] de Vries, L., Grushka, Y., Lebenthal, Y., Shalitin, S. and Philip, M. (2010) Factors Associated with Increased Risk of Insulinpump Discontinuation in Pediatric Patients with Type 1 Diabetes. Pediatric Diabetes, 12, 506-512.

Copyright © 2020 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.